Skip to content
Parakho

Biocon Ltd

NSE BIOCONBSE 532523biocon.comInvestor relations

Q1 FY27, unaudited

Revenue
₹624.50 Cr
Profit after tax
₹52.20 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations624.50+16.27%2,346.40
Other income64.80+5.71%319.70
Total income689.30+15.19%2,666.10
Employee benefit expense133.10+5.89%467.20
Finance costs17.30−69.22%142.40
Depreciation & amortisation38.40+15.32%137.30
Total expenses619.40+2.21%2,400.00
Profit before tax69.90+1,019.74%51.00
Tax expense17.70+2,428.57%13.80
Profit after tax52.20+728.92%37.20
Total comprehensive income63.80+528.19%18.00
Earnings per share
Earnings per share, basic₹0.32₹0.27
Earnings per share, diluted₹0.32₹0.27

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Biocon reported 10% year-on-year growth in group operating revenue for Q1 FY27, with biopharmaceuticals growing 17% while services revenue declined 16% due to lower offtake from a key biologics client. EBITDA stood at INR902 crores at a 21% margin, and reported net profit before exceptionals rose 245% year-on-year to INR145 crores. Management discussed segment performance across biosimilars, generics and Syngene, and addressed questions on profitability drivers, working capital, debt, US tariff risk, and the Bicara stake.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 86 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 18 Aug 2026.